Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

ENGN

enGene (ENGN)

enGene Holdings Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ENGN
DateTimeSourceHeadlineSymbolCompany
09/26/20246:30AMBusiness WireDetalimogene Demonstrates 71% Complete Response Rate at Any Time in Preliminary Analysis of LEGEND Pivotal CohortNASDAQ:ENGNenGene Holdings Inc
09/10/20244:33PMBusiness WireenGene Reports Third Quarter 2024 Financial Results and Provides a Business UpdateNASDAQ:ENGNenGene Holdings Inc
08/28/20244:05PMBusiness WireenGene to Participate in Upcoming Investor ConferencesNASDAQ:ENGNenGene Holdings Inc
07/24/20244:05PMBusiness WireenGene Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)NASDAQ:ENGNenGene Holdings Inc
07/24/20246:30AMBusiness WireenGene Announces Appointment of Ron Cooper as Chief Executive OfficerNASDAQ:ENGNenGene Holdings Inc
07/18/20248:00AMGlobeNewswire Inc.NewAmsterdam Pharma Announces Appointments of Mark C. McKenna and Wouter Joustra to its Board of DirectorsNASDAQ:ENGNenGene Holdings Inc
06/14/20247:01AMBusiness WireenGene Reports Second Quarter 2024 Financial Results and Provides a Business UpdateNASDAQ:ENGNenGene Holdings Inc
05/29/20247:30AMBusiness WireenGene to Present at the Jefferies Global Healthcare ConferenceNASDAQ:ENGNenGene Holdings Inc
05/15/20244:05PMBusiness WireenGene Announces the Election of Paul Hastings and Wouter Joustra to its Board of DirectorsNASDAQ:ENGNenGene Holdings Inc
05/02/20244:05PMPR Newswire (US)enGene to Present Details of its Pivotal Phase 1/2 LEGEND Study of EG-70 in BCG-Unresponsive Non-Muscle Invasive Bladder Cancer with Carcinoma in situ at the American Urology Association 2024 Annual MeetingNASDAQ:ENGNenGene Holdings Inc
05/02/20244:05PMPR Newswire (Canada)enGene to Present Details of its Pivotal Phase 1/2 LEGEND Study of EG-70 in BCG-Unresponsive Non-Muscle Invasive Bladder Cancer with Carcinoma in situ at the American Urology Association 2024 Annual MeetingNASDAQ:ENGNenGene Holdings Inc
04/09/20248:56AMPR Newswire (US)/C O R R E C T I O N -- enGene Inc./NASDAQ:ENGNenGene Holdings Inc
04/09/20248:00AMPR Newswire (Canada)engender Announces Hiring of Dr. Raja Ruth as Senior Vice President, Urologic Oncology and Clinical DevelopmentNASDAQ:ENGNenGene Holdings Inc
04/09/20248:00AMPR Newswire (US)engender Announces Hiring of Dr. Raja Ruth as Senior Vice President, Urologic Oncology and Clinical DevelopmentNASDAQ:ENGNenGene Holdings Inc
03/11/20245:16PMPR Newswire (US)enGene Reports First Quarter 2024 Financial Results and Recent Corporate ProgressNASDAQ:ENGNenGene Holdings Inc
03/11/20245:16PMPR Newswire (Canada)enGene Reports First Quarter 2024 Financial Results and Recent Corporate ProgressNASDAQ:ENGNenGene Holdings Inc
03/05/20247:00AMPR Newswire (US)enGene To Present at the Leerink Partners Global Biopharma ConferenceNASDAQ:ENGNenGene Holdings Inc
03/05/20247:00AMPR Newswire (Canada)enGene To Present at the Leerink Partners Global Biopharma ConferenceNASDAQ:ENGNenGene Holdings Inc
02/14/20246:50AMPR Newswire (US)enGene Announces Oversubscribed $200 Million Private Placement FinancingNASDAQ:ENGNenGene Holdings Inc
02/14/20246:50AMPR Newswire (Canada)enGene Announces Oversubscribed $200 Million Private Placement FinancingNASDAQ:ENGNenGene Holdings Inc
02/14/20246:45AMPR Newswire (Canada)enGene Announces Leadership Succession PlanNASDAQ:ENGNenGene Holdings Inc
02/14/20246:45AMPR Newswire (US)enGene Announces Leadership Succession PlanNASDAQ:ENGNenGene Holdings Inc
01/30/20247:00AMPR Newswire (Canada)enGene Appoints Lee Giguere as Chief Legal Officer and Corporate SecretaryNASDAQ:ENGNenGene Holdings Inc
01/30/20247:00AMPR Newswire (US)enGene Appoints Lee Giguere as Chief Legal Officer and Corporate SecretaryNASDAQ:ENGNenGene Holdings Inc
01/29/20247:00AMPR Newswire (US)enGene Reports Full Year 2023 Financial Results and Recent Operational ProgressNASDAQ:ENGNenGene Holdings Inc
01/29/20247:00AMPR Newswire (Canada)enGene Reports Full Year 2023 Financial Results and Recent Operational ProgressNASDAQ:ENGNenGene Holdings Inc
12/22/20235:00PMPR Newswire (US)enGene Announces Expanded $50 Million Debt Facility with Hercules CapitalNASDAQ:ENGNenGene Holdings Inc
12/22/20235:00PMPR Newswire (Canada)enGene Announces Expanded $50 Million Debt Facility with Hercules CapitalNASDAQ:ENGNenGene Holdings Inc
12/19/20237:00AMPR Newswire (US)enGene Appoints Lota S. Zoth, CPA, as Member of the Board of DirectorsNASDAQ:ENGNenGene Holdings Inc
12/19/20237:00AMPR Newswire (Canada)enGene Appoints Lota S. Zoth, CPA, as Member of the Board of DirectorsNASDAQ:ENGNenGene Holdings Inc
 Showing the most relevant articles for your search:NASDAQ:ENGN